34 results
Thumbnail

D2.480 - Features of the molecular sensitization profile in children with autism spectrum disorder

Thumbnail

D2.485 - Comprehensive Understanding of the Characteristics of Pediatric Pollen Allergy Patients

Thumbnail

D2.486 - Levels of house dust mite in dust settlements are associated with risk for allergic rhinitis in children

Thumbnail

D2.489 - B-Cell Subset Reconstitution After Rituximab-Containing Chemotherapy in Children and Adolescents With Non-Hodgkin Lymphoma: A Single-Center Experience

Thumbnail

D2.478 - HEREDITORY ANGIOEDEMA - A case report

Thumbnail

D2.477 - Nationwide Survey of Healthcare Transition from Paediatric to Adult Services for Allergic Diseases in Japan

Thumbnail

D2.479 - The bullous pemphigoid in a baby

Thumbnail

D2.481 - Severe obstructive syndrome in children with bronchopulmonary malformations

Thumbnail

D2.482 - Neuroendocrine Cell Hyperplasia of Infancy (NEHI): Report of 7 Cases

Thumbnail

D2.483 - Outdoor Activity and Screen Time at Age 3 years and Allergic Symptoms at Age 6 years: A Nationwide Birth Cohort Study (JECS)

Thumbnail

D2.487 - Avoiding Unnecessary Food Avoidance: Outcomes of Infants with Localised Reactions During Weaning

Thumbnail

D2.488 - Functional confirmation of exercise-induced bronchoconstriction in children: A three-year retrospective study

Thumbnail

D3.418 - A Phase 1b Study of Lesigercept, a Long-acting High-affinity IgETrap-Fc Fusion Protein: Safety, Tolerability, PK, and PD in Atopic Healthy and Allergic Subjects

Thumbnail

D3.419 - Efficacy, safety, and remission outcomes of omalizumab in elderly patients with severe allergic asthma: a subgroup analysis by age of onset

Thumbnail

D3.420 - Real-world epidemiologic characteristics of patients treated with dupilumab for type 2 inflammatory indications: a single-center retrospective cohort study

Thumbnail

D3.421 - Real-world Effectiveness and Safety of Lanadelumab Treatment in Patients With Hereditary Angioedema: The 12-Month Interim Analysis of a Polish, Prospective, Multicenter, Observational Study (CHOPIN)

Thumbnail

D3.422 - Dupilumab in children with multimorbid atopic phenotype: therapy efficacy, safety and biomarker changes

Thumbnail

D3.423 - Lanadelumab treatment is effective and safe in patients with Factor XII associated cold-induced autoinflammatory syndrome: results from an open-label proof-of-concept study

Thumbnail

D3.424 - Retrospective Analysis of Self-Administration of Biologic Treatments for Severe Asthma and Chronic Urticaria

Thumbnail

D3.426 - Predicting response to omalizumab in patients with chronic spontaneous urticaria: The first results of the global multicenter UCARE SCOPUS project